Prescribed by oncologists for the treatment of adult men with: 🔹 Metastatic Castration-Resistant Prostate Cancer (mCRPC): For patients who are asymptomatic/mildly symptomatic or those whose disease has progressed on or after a docetaxel-based chemotherapy regimen. 🔹 Metastatic High-Risk Castration-Sensitive Prostate Cancer (mHSPC): In combination with androgen deprivation therapy (ADT).

Dosage and administration

Sales Unit: Film-coated tablets, 250 mg strength. ⚠️ APPLICATION INSTRUCTIONS: Standard Dosage: 1000 mg (four 250 mg tablets) taken orally once daily. Critical Administration Rule: Take on an empty stomach. No food should be consumed for at least 2 hours before and 1 hour after the dose. Taking with food significantly increases absorption and risk of toxicity. 💊 Co-administration: Must be taken with low-dose prednisone or prednisolone as prescribed to manage fluid retention and hypertension. Method: Swallow tablets whole with water. Do not crush or chew.

⛔ Women & Pregnancy: Strictly contraindicated. Pregnant women should not even handle the tablets without protection (Category X). Hypersensitivity to Abiraterone Acetate. Severe hepatic impairment (liver failure). Pediatric use is not permitted.

Regular monitoring of blood pressure, serum potassium, and liver enzymes is mandatory. Potential side effects include: 💧 Fluid Retention: Peripheral edema (swelling of legs/feet). 🍌 Hypokalemia: Low blood potassium levels. 📈 Hypertension: High blood pressure. 🔶 Hepatotoxicity: Elevated liver enzymes (ALT/AST). 🚽 Infections: Urinary tract infections (UTI).

Abiraxen — Abiraterone Acetate 250 mg, 28 product-page.units_short, Everest

100% original product

Active ingredient

Abiraterone Acetate

Manufacturer

Everest

Dosage 250 mg

Dosage form Tablets

Tablets per pack 28

Abiraxen Tablets — Abiraterone 250 mg (28 Tabs) Everest

Name: Abiraxen
Brand: Everest
SKU: PROD-212
Price: 18815 UAH
Availability: InStock

18815₴ ~~20565₴~~ -9%

Abiraxen 250 mg (Abiraterone Acetate) is a potent hormonal therapy for prostate cancer and a generic equivalent to Zytiga. It works by inhibiting the CYP17 enzyme, which is crucial for androgen biosynthesis. By blocking this enzyme, Abiraxen stops the production of testosterone — the hormone that drives prostate cancer growth — in the testes, adrenal glands, and the tumor itself.

Manufacturer: Everest Pharmaceuticals (Bangladesh). This drug is a cornerstone in the treatment of advanced prostate cancer.

Key Features:

✅ Comprehensive Inhibition: Blocks androgen production at all three sources (testes, adrenal glands, tumor tissue).
✅ Proven Efficacy: Significantly increases overall survival in patients with metastatic prostate cancer.
✅ Combination Use: Administered alongside prednisone to mitigate mineralocorticoid-related side effects.

Prescribed by oncologists for the treatment of adult men with:

🔹 Metastatic Castration-Resistant Prostate Cancer (mCRPC): For patients who are asymptomatic/mildly symptomatic or those whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
🔹 Metastatic High-Risk Castration-Sensitive Prostate Cancer (mHSPC): In combination with androgen deprivation therapy (ADT).

Sales Unit: Film-coated tablets, 250 mg strength.

⚠️ APPLICATION INSTRUCTIONS:

Standard Dosage: 1000 mg (four 250 mg tablets) taken orally once daily.
Critical Administration Rule: Take on an empty stomach. No food should be consumed for at least 2 hours before and 1 hour after the dose. Taking with food significantly increases absorption and risk of toxicity.
💊 Co-administration: Must be taken with low-dose prednisone or prednisolone as prescribed to manage fluid retention and hypertension.
Method: Swallow tablets whole with water. Do not crush or chew.

⛔ Women & Pregnancy: Strictly contraindicated. Pregnant women should not even handle the tablets without protection (Category X).
Hypersensitivity to Abiraterone Acetate.
Severe hepatic impairment (liver failure).
Pediatric use is not permitted.